share_log

海思科:非公开发行股票申请获得证监会核准批文

Hesco: the application for non-public offering of shares is approved by the Securities and Futures Commission

China Fortune IR ·  May 5, 2022 02:40

Release May 5-Haisk (002653) announced that the company recently received a "reply on approving the non-public offering of shares of Haiscox Pharmaceutical Group Co., Ltd." issued by the China Securities Regulatory Commission, approving the non-public offering of no more than 40 million new shares.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment